Description
Tesamorelin is a stabilised GHRH analogue, modified at the N-terminus to resist enzymatic degradation by DPP-4 — a different stabilisation strategy from the albumin-binding approach used in CJC-1295 with DAC. That distinction makes tesamorelin a useful comparison point in research on visceral adipose tissue and GHRH-axis pharmacokinetics.
Tesamorelin has one of the more substantial published trial datasets among GHRH analogues, particularly around visceral fat reduction, which is why it’s frequently requested as a reference compound in comparative lipid-metabolism research.
After you place your order, a licensed physician will speak with you directly on a live call to review your health history and confirm a prescription is medically appropriate before anything ships. If your order isn’t approved, our team will contact you directly instead of shipping it. Reconstitute with bacteriostatic water and store refrigerated, protected from light.
